<?xml version="1.0" encoding="UTF-8"?>
<p>PLpro is one of the nonstructural proteins encoded by the SARS-CoV-2 genome. This protease is vital for virus replication since it contributes to the cleavage of viral polyproteins (PP1A and PP1AB) into effector proteins (
 <xref rid="B33" ref-type="bibr">Jiang et al., 2020</xref>). Moreover, PLpro has been found to be an antagonist of the host’s innate immunity (
 <xref rid="B102" ref-type="bibr">Yuan et al., 2015</xref>; 
 <xref rid="B45" ref-type="bibr">Li et al., 2016</xref>). Actually, PLpro was shown to target the interferon production by blocking the IRF3 phosphorylation, dimerization, and nuclear translocation and NF-κB signaling pathways (by preventing IκBα degradation) (
 <xref rid="B91" ref-type="bibr">Wong et al., 2016</xref>). These effects were shown to occur in Toll-like receptor 3 and retinoic acid-inducible gene 1 pathways. Moreover, it has been demonstrated that SARS-CoV PLpro inhibits the TLR7 pathway 
 <italic>via</italic> inactivation of TRAF3/6-TBK1-IRF3/NF-κB/AP1 signalling pathways (
 <xref rid="B102" ref-type="bibr">Yuan et al., 2015</xref>).
</p>
